Evidence map›Paper›PMID 30573652›Full record

Observational studyDiabetes care2019

Impact of Early Diabetic Ketoacidosis on the Developing Brain.

Tandy Aye, Paul K Mazaika, Nelly Mauras, Matthew J Marzelli, Hanyang Shen, Tamara Hershey, Allison Cato, Stuart A Weinzimer, Neil H White, Eva Tsalikian and 3 more

Registry-linked trialOpen access · bronzeAbstract readObservational Study
In one paragraph

Observational study in Diabetes care, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01753934 (Diabetic Ketoacidosis and Its Impact on Neurocognition), which is not on this map. Cited by 69 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 2 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01753934 completednot on this map

Diabetic Ketoacidosis and Its Impact on Neurocognition

TypeobservationalSponsorStanford UniversityRan2011 to 2013Enrolled24ConditionsDiabetes Mellitus
3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 2 syntheses or guidelines pooled it, 129 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Tandy AyeDivision of Pediatric Endocrinology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA taye@stanford.edu.ORCID http://orcid.org/0000-0002-9005-3303
Paul K MazaikaCenter for Interdisciplinary Brain Sciences Research, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA.ORCID http://orcid.org/0000-0002-9464-6333
Nelly MaurasDivision of Pediatric Endocrinology, Department of Pediatrics, Nemours Children's Health System, Jacksonville, FL.
Matthew J MarzelliCenter for Interdisciplinary Brain Sciences Research, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA.
Hanyang ShenCenter for Interdisciplinary Brain Sciences Research, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA.
Tamara HersheyDepartments of Psychiatry and Radiology, Washington University School of Medicine, St. Louis, MO.
Allison CatoDivision of Neurology, Department of Pediatrics, Nemours Children's Health System, Jacksonville, FL.
Stuart A WeinzimerSection of Pediatric Endocrinology, Department of Pediatrics, Yale University, New Haven, CT.
Neil H WhiteDivision of Endocrinology and Diabetes, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO.
Eva TsalikianDivision of Endocrinology and Diabetes, Stead Family Department of Pediatrics, University of Iowa, Iowa City, IA.
Booil JoCenter for Interdisciplinary Brain Sciences Research, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA.
Allan L Reiss
Diabetes Research in Children Network (DirecNet) Study Group
Stanford University · USNemours Children's Health System · USWashington University in St. Louis · USUniversity of Iowa · USYale University · US

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Washington University Institute of Clinical and Translational Sciences (UL1)UL1RR024992 · NCRR · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2007 to 2011
$45.4M
Type 1 diabetes and the brain in children: Metabolic interventionsR01HD078463 · NICHD · NEMOURS CHILDREN'S CLINIC · PI MAURAS, NELLY, REISS, ALLAN L · 2014 to 2018
$9.9M
Washington University Intellectual and Developmental Disabilities Research Center-Administrative Down Syndrome SupplementU54HD087011 · NICHD · WASHINGTON UNIVERSITY · PI CONSTANTINO, JOHN N. · 2015 to 2019
$7.1M
Yale Study of Closed-Loop Automated Glucose Control for Hypoglycemia PreventionU10HD041906 · NICHD · YALE UNIVERSITY · PI WEINZIMER, STUART ALAN · 2001 to 2011
$3.6M
Prevention of Nocturnal Hypoglycemia: Effect on Neurologic Outcome in ToddlersU10HD041908 · NICHD · STANFORD UNIVERSITY · PI BUCKINGHAM, BRUCE A · 2001 to 2011
$3.5M
Prevention of Hypoglycemia and Associated Complications in Type 1 DiabetesU10HD041915 · NICHD · UNIVERSITY OF IOWA · PI TSALIKIAN, EVA · 2001 to 2011
$3.4M
Hypoglycemia in Children and Adolescents with T1DM: Mechanisms and PreventionU10HD041918 · NICHD · NEMOURS CHILDREN'S CLINIC · PI MAURAS, NELLY · 2001 to 2011
$3.1M
Diabetes Research in Children Network (DirecNet)U10HD056526 · NICHD · WASHINGTON UNIVERSITY · PI WHITE, NEIL H. · 2007 to 2011
$1.4M
NCATS NIH HHS UL1 TR002345NCRR NIH HHS UL1 RR024992NICHD NIH HHS R01 HD078463NICHD NIH HHS U10 HD041906NICHD NIH HHS U10 HD041908NICHD NIH HHS U10 HD041915NICHD NIH HHS U10 HD041918NICHD NIH HHS U10 HD056526NICHD NIH HHS U54 HD087011
6 · The paper itself

Abstract

objectiveThis study examined whether a history of diabetic ketoacidosis (DKA) is associated with changes in longitudinal cognitive and brain development in young children with type 1 diabetes. RESEARCH DESIGN AND

methodsCognitive and brain imaging data were analyzed from 144 children with type 1 diabetes, ages 4 to <10 years, who participated in an observational study of the Diabetes Research in Children Network (DirecNet). Participants were grouped according to history of DKA severity (none/mild or moderate/severe). Each participant had unsedated MRI scans and cognitive testing at baseline and 18 months.

resultsIn 48 of 51 subjects, the DKA event occurred at the time of onset, at an average of 2.9 years before study entry. The moderate/severe DKA group gained more total and regional white and gray matter volume over the observed 18 months compared with the none/mild group. When matched by age at time of enrollment and average HbA

conclusionsA single episode of moderate/severe DKA in young children at diagnosis is associated with lower cognitive scores and altered brain growth. Further studies are needed to assess whether earlier diagnosis of type 1 diabetes and prevention of DKA may reduce the long-term effect of ketoacidosis on the developing brain.

Indexed as

Age of OnsetBrainCase-Control StudiesChildChild, PreschoolCognitionCognition DisordersDiabetes Mellitus, Type 1Diabetic KetoacidosisFemaleFunctional NeuroimagingHumansMagnetic Resonance ImagingMaleSeverity of Illness Index

Identifiers

PMID30573652
PMCPMC6385695
OpenAlexW2906031105

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.